Company Overview of Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc., a biopharmaceutical company, develops stapled peptide drugs. The company focuses on candidates targeting cancer, infectious, metabolic, and immune/inflammatory diseases. Its stapled peptides penetrate cells throughout the body; and modulate intracellular and extracellular protein-protein interactions, and critical control points for human diseases. The company has a strategic partnership with Roche. Aileron Therapeutics, Inc. was formerly known as Renegade Therapeutics, Inc. The company was incorporated in 2001 and is based in Cambridge, Massachusetts.
281 Albany Street
Cambridge, MA 02139
Founded in 2001
Key Executives for Aileron Therapeutics, Inc.
Aileron Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Nucleico, LLC||United States|
|ARx, LLC||United States|
|Replicon Technologies, Inc.||United States|
|Nurel Therapeutics, Inc.||United States|
|GX Healthcare LLC||United States|
Recent Private Companies Transactions
November 5, 2013
To contact Aileron Therapeutics, Inc., please visit www.aileronrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.